[1][2] A February 2023 survey for Mamedica found a third of respondents would use medical marijuana to help treat depression.
[3] In June 2023, Mamedica announced a strategic UK partnership with Canadian medical cannabis products supplier 4C Labs.
[5] Robson says the clinic aims "to offer an alternative to conventional medicines to individuals who are struggling with a severe medical condition and desire to regain a sense of normalcy in their daily lives".
[9] In addition, the clinic prescribes CBD to support patients with menopause symptoms like hot flushes,[10] and the clinic supports patients living with chronic neurological pain, with bespoke cannabis-based prescription medicines (CBPMs) that improve individuals' overall quality of life by reducing symptoms of depression and anxiety.
[13] Before patients can book a Mamedica consultation, they need to have tried at least two licensed medications or treatments and must not have any history of schizophrenia or psychosis.